Advanced search
Publication Cover
Biomarkers Volume 17, 2012 - Issue 5
Submit an article Journal homepage
128
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Development of an immunoassay for the derived-peptide of chromogranin A, Vasostatin-I (1-76): assessment of severity in patients with sepsis

Hélène ChungCisbio Bioassays, Codolet, France
,
Angelo CortiDivision of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy
,
Luca CrippaDivision of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy
,
Francis SchneiderService de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
,
Marie-Hélène Metz-BoutigueLaboratoire des Biomatériaux et Ingénierie Tissulaire, Université de Strasbourg, Strasbourg, France
&
Patrick GarneroCisbio Bioassays, Codolet, FranceCorrespondence[email protected]
Pages 430-434 | Received 02 Feb 2012, Accepted 26 Mar 2012, Published online: 23 Apr 2012

References

  • Becker KL, Snider R, Nylen ES. (2010). Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159:253–264.
  • Belloni D, Scabini S, Foglieni C, Veschini L, Giazzon A, Colombo B, Fulgenzi A, Helle KB, Ferrero ME, Corti A, Ferrero E. (2007). The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration. FASEB J 21:3052–3062.
  • Bone RC, Sibbald WJ, Sprung CL. (1992). The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481–1483.
  • Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, Parrinello G, Corti A. (2002). Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 23:967–974.
  • Conlon JM. (2010). Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors. Regul Pept 165:5–11.
  • Corti A, Sanchez LP, Gasparri A, Curnis F, Longhi R, Brandazza A, Siccardi AG, Sidoli A. (1997). Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) – evidence of dimer-monomer equilibria. Eur J Biochem 248:692–699.
  • Glattard E, Angelone T, Strub JM, Corti A, Aunis D, Tota B, Metz-Boutigue MH, Goumon Y. (2006). Characterization of natural vasostatin-containing peptides in rat heart. FEBS J 273:3311–3321.
  • Helle KB. (2010). The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc Res 85:9–16.
  • Helle KB, Corti A, Metz-Boutigue MH, Tota B. (2007). The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64:2863–2886.
  • Ivády B, Béres BJ, Szabó D. (2011). Recent advances in sepsis research: novel biomarkers and therapeutic targets. Curr Med Chem 18:3211–3225.
  • Lever A, Mackenzie I. (2007). Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879–883.
  • Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B, Aunis D, Metz-Boutigue MH. (2001). Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J Biol Chem 276:35875–35882.
  • Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH. (2000). Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 275:10745–10753.
  • Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D. (1993). Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217:247–257.
  • Pierrakos C, Vincent JL. (2010). Sepsis biomarkers: a review. Crit Care 14:R15.
  • Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, Cerra MC, Bellocci F, Crea F, Maseri A. (2007). Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J 28:1117–1127.
  • Roatta S, Passatore M, Novello M, Colombo B, Dondossola E, Mohammed M, Losano G, Corti A, Helle KB. (2011). The chromogranin A- derived N-terminal peptide vasostatin-I: In vivo effects on cardiovascular variables in the rabbit. Regul Pept 168:10–20.
  • Zhang D, Lavaux T, Voegeli AC, Lavigne T, Castelain V, Meyer N, Sapin R, Aunis D, Metz-Boutigue MH, Schneider F. (2008). Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit. Clin Chem 54:1497–1503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.